95 studies found for:    "mucopolysaccharidosis type IV"
Show Display Options
Rank Status Study
21 Active, not recruiting Study of BMN 110 in Pediatric Patients < 5 Years of Age With Mucopolysaccharidosis IVA (Morquio A Syndrome)
Conditions: Mucopolysaccharidosis IVA;   Morquio A Syndrome;   MPS IVA
Intervention: Drug: BMN 110
22 Active, not recruiting Rubinstein-Taybi Syndrome: Functional Imaging and Therapeutic Trial
Condition: Rubinstein-Taybi Syndrome
Interventions: Drug: sodium valproate;   Drug: Placebo
23 Recruiting Natural History of Cherubism Observational Study
Condition: Cherubism
Intervention: Other: no interventions
24 Terminated A Multi-centre Study to Assess the Long-term Performance of the DePuy ASR™ System in Primary Hip Resurfacing Surgery
Conditions: Rheumatoid Arthritis;   Osteoarthritis;   Post-traumatic Arthritis;   Collagen Disorders;   Avascular Necrosis;   Nonunion of Femoral Fractures;   Congenital Hip Dysplasia;   Slipped Capital Femoral Epiphysis.
Intervention: Device: DePuy ASR Hip System
25 Completed A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers
Condition: Achondroplasia
Interventions: Drug: BMN 111;   Drug: Normal Saline
26 Terminated rhPTH Therapy for Low Turnover Bone Fragility
Condition: Osteopetrosis
Intervention: Drug: rhPTH
27 Recruiting Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Intervention: Biological: Mesenchymal Stem Cells
28 Recruiting MT2013-31:Allo BMT for Metabolic Disorders, Osteopetrosis and Males With Rett Syndrome
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Rett Syndrome;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
29 Completed Effect of High-Dose Vitamin D on Bone Density in Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Interventions: Dietary Supplement: standard-dose vitamin D (400IU per day);   Dietary Supplement: high-dose vitamin D (2000 IU per day)
30 Recruiting Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project
Condition: Exostoses, Multiple Hereditary
Intervention:
31 Recruiting Allogeneic Transplantation For Severe Osteopetrosis
Condition: Severe Osteopetrosis
Interventions: Procedure: umbilical cord blood transplantation;   Drug: Campath-1H;   Radiation: Total Lymphoid Irradiation;   Drug: Cyclophosphamide;   Drug: Busulfan;   Drug: Fludarabine monophosphate;   Procedure: marrow graft transplantation
32 Terminated A Randomised Multi-centre Study to Compare the Long-term Performance of the Future Hip to 3 Other Implants in Primary Total Hip Replacement
Conditions: Osteoarthritis;   Post-traumatic Arthritis;   Collagen Disorders;   Avascular Necrosis;   Traumatic Femoral Fractures;   Nonunion of Femoral Fractures;   Congenital Hip Dysplasia;   Slipped Capital Femoral Epiphysis;   Perthes Disease
Interventions: Device: Future Hip;   Device: Omniflex;   Device: Zueymüller;   Device: CLS Spotorno
33 Active, not recruiting Trial of Lithium Carbonate for Treatment of Osteoporosis-pseudoglioma Syndrome
Condition: Osteoporosis Pseudoglioma
Intervention: Drug: Lithium
34 Suspended The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses
Condition: Exostoses, Multiple Hereditary
Intervention:
35 Unknown  Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis
Condition: Osteopetrosis
Interventions: Drug: Busulfan, Cyclophosphamide, Thymoglobulin, Fludarabine (Conditioning regimen);   Procedure: Stem Cell Transplantation;   Drug: Cyclosporin, Methotrexate (GVHD prophylaxis)
36 Active, not recruiting Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab
Condition: Osteogenesis Imperfecta
Intervention: Drug: Denosumab
37 Terminated Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC
Condition: Exostoses, Multiple Hereditary
Intervention:
38 Recruiting The Effect of Treatment With Teriparatide and Zoledronic Acid in Patients With Osteogenesis Imperfecta
Condition: Osteogenesis Imperfecta
Interventions: Drug: Zoledronic acid;   Drug: Teriparatide;   Drug: placebo zoledronic acid;   Drug: placebo teriparatide
39 Recruiting Screening and Natural History of Patients With Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome
Condition: Polyostotic Fibrous Dysplasia
Intervention:
40 Completed A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia
Intervention: Drug: Pegvisomant

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years